PARP inhibitors for prostate cancer: What oncology PAs should know
PARP inhibitors for prostate cancer: What oncology PAs should know
APAO: Current initiatives and hopes for the future
How COVID-19 has impacted oncology nursing practice and guidelines
Big data, machine learning and drug discovery in oncology
ESMO 2020: New developments in the treatment of lung cancer
SABCS 2020: Conference roundup
PRWCC: Disease burden impacts outcomes in paediatric and young adult B-Cell ALL after commercial tisagenlecleucel
Researchers trace the origin of blood cancer to early childhood, decades before diagnosis
Risk profiling of relapsed/refractory diffuse large B-cell lymphoma patients by measuring circulating tumour DNA
ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma
Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the randomised Forte trial
Circulating tumour cell dynamics as a predictor for treatment response and prognosis in metastatic breast cancer patients